(Q46493211)

22 December 2017

title

Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors (English)

1 reference

22 December 2017

0 references

1 reference

1 reference

Li-Rung Chen

1

1 reference

22 December 2017

Yu-Chin Wang

2

1 reference

22 December 2017

Yi Wen Lin

3

1 reference

22 December 2017

Shan-Yen Chou

4

1 reference

22 December 2017

Shyh-Fong Chen

5

1 reference

22 December 2017

Lee Tai Liu

6

1 reference

22 December 2017

Ying-Ta Wu

7

1 reference

22 December 2017

Chih-Jung Kuo

8

1 reference

22 December 2017

Tom Shieh-Shung Chen

9

1 reference

22 December 2017

Shin-Hun Juang

10

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

22 December 2017

Bioorganic & Medicinal Chemistry Letters

published in

1 reference

22 December 2017

volume

15

1 reference

22 December 2017

issue

12

1 reference

22 December 2017

page(s)

3058-3062

1 reference

22 December 2017

Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.

cites work

1 reference

12 December 2020

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

1 reference

12 December 2020

Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase

1 reference

12 December 2020

Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.

1 reference

12 December 2020

Clinical presentations and outcome of severe acute respiratory syndrome in children.

1 reference

12 December 2020

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

1 reference

12 December 2020

Identifying inhibitors of the SARS coronavirus proteinase

1 reference

12 December 2020

Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.

1 reference

12 December 2020

Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro

1 reference

12 December 2020

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate

1 reference

12 December 2020

Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design

1 reference

12 December 2020

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase

1 reference

12 December 2020

Small molecules targeting severe acute respiratory syndrome human coronavirus

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Development of a standard treatment protocol for severe acute respiratory syndrome

1 reference

12 December 2020

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

1 reference

12 December 2020

Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease

1 reference

12 December 2020

10.1016/J.BMCL.2005.04.027

Identifiers

DOI

1 reference

22 December 2017

0 references

0 references

1 reference

22 December 2017